Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment

NB Abdol Razak, G Jones, M Bhandari, MC Berndt… - Cancers, 2018 - mdpi.com
Cancer-associated thrombosis is a major cause of mortality in cancer patients, the most
common type being venous thromboembolism (VTE). Several risk factors for developing …

Cancer-associated pathways and biomarkers of venous thrombosis

Y Hisada, N Mackman - Blood, The Journal of the American …, 2017 - ashpublications.org
Cancer patients have an increased risk of venous thromboembolism (VTE). In this review,
we summarize common and cancer type–specific pathways of VTE in cancer patients …

Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology

MB Streiff, B Holmstrom, D Angelini, A Ashrani… - Journal of the National …, 2021 - jnccn.org
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Associated
Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of …

Potentially curable pancreatic cancer: American Society of Clinical Oncology clinical practice guideline

AA Khorana, PB Mangu, J Berlin… - Journal of Clinical …, 2016 - ascopubs.org
Purpose To provide evidence-based recommendations to oncologists and others on
potentially curative therapy for patients with localized pancreatic cancer. Methods ASCO …

Locally advanced, unresectable pancreatic cancer: American Society of Clinical Oncology clinical practice guideline

EP Balaban, PB Mangu, AA Khorana… - Journal of Clinical …, 2016 - ascopubs.org
Purpose To provide evidence-based recommendations to oncologists and others for
treatment of patients with locally advanced, unresectable pancreatic cancer. Methods …

Metastatic pancreatic cancer: American Society of Clinical Oncology clinical practice guideline

DPS Sohal, PB Mangu, AA Khorana… - Journal of Clinical …, 2016 - ascopubs.org
Purpose To provide evidence-based recommendations to oncologists and others for the
treatment of patients with metastatic pancreatic cancer. Methods American Society of …

The incidence of cancer-associated thrombosis is increasing over time

A Mahajan, A Brunson, O Adesina… - Blood …, 2022 - ashpublications.org
Cancer-associated thrombosis (CAT) is an important cause of morbidity and mortality for
patients with malignancy and varies by primary cancer type, stage, and therapy. We aimed …

Development and validation of a predictive model for chemotherapy-associated thrombosis

AA Khorana, NM Kuderer, E Culakova… - Blood, The Journal …, 2008 - ashpublications.org
Risk of venous thromboembolism (VTE) is elevated in cancer, but individual risk factors
cannot identify a sufficiently high-risk group of outpatients for thromboprophylaxis. We …

Assessing risk of venous thromboembolism in the patient with cancer

AA Khorana, GC Connolly - Journal of Clinical Oncology, 2009 - ascopubs.org
Purpose Patients with cancer are increasingly at risk for venous thromboembolism (VTE).
Rates of VTE, however, vary markedly among patients with cancer. Design This review …

Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial

JS De Bono, N Concin, DS Hong… - The lancet …, 2019 - thelancet.com
Background Tisotumab vedotin is a first-in-human antibody–drug conjugate directed against
tissue factor, which is expressed across multiple solid tumour types and is associated with …